Research ArticleOriginal Article

Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer

Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727

Article Information

vol. 19 no. 8 1249-1258
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2020.0727
Published By 
Cancer Biology & Medicine
History 
  • Received November 26, 2020
  • Accepted April 12, 2021
  • Published online August 29, 2022.

Article Versions

Copyright & Usage 
Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Cuicui Zhang1,
  2. Jing Wang1,
  3. Xinyue Wang1,
  4. Zhaoting Meng1,
  5. Ying Cheng2⇑ and
  6. Kai Li1⇑
  1. 1Department of Thoracic Oncology Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
  2. 2Jilin Cancer Hospital, Changchun 130021, China
  1. Correspondence to: Kai Li and Ying Cheng, E-mail: likai_fnk{at}163.com and chengying{at}csco.org.cn
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords